These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4086728)

  • 1. In vivo administration of propranolol delays development of a murine plasmacytoma tumor.
    Grzanna R; Frondoza CG; Hung GL; Sastre A
    J Auton Nerv Syst; 1985 Dec; 14(4):397-401. PubMed ID: 4086728
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-surface major glycoprotein of BALB/c mouse plasmacytoma 58-8 cells.
    Tokuyama H; Migita S
    J Natl Cancer Inst; 1978 Jul; 61(1):203-8. PubMed ID: 276626
    [No Abstract]   [Full Text] [Related]  

  • 3. Biosynthesis, intracellular transport, and secretion of immunoglobulins. Effect of 2-deoxy-D-glucose in tumor plasma cells producing and secreting immunoglobulin G1.
    Melchers F
    Biochemistry; 1973 Apr; 12(8):1471-6. PubMed ID: 4735535
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synthesis of messenger-like RNA in plasma cels producing different clases of immunoglobulins].
    Nikitin AV; Babichev VA
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):74-7. PubMed ID: 1024448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins, but not tumor-derived IL-10, shut down concomitant tumor-specific CTL responses during murine plasmacytoma progression.
    Specht C; Bexten S; Kölsch E; Pauels HG
    Int J Cancer; 2001 Mar; 91(5):705-12. PubMed ID: 11267984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction of drug resistance to sarcolysine in plasmacytoma line MORC/406].
    Khomchenovskiĭ EI; Burova GF
    Biull Eksp Biol Med; 1985 Jan; 99(1):90-1. PubMed ID: 3967079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proliferation-associated cytosolic protein Lap18 (stathmin) is expressed at atypically low levels in BALB/c plasmacytoma cells.
    Rowlands DC; Jones NA; Brown G; Potter M; Muschinski B; Maclennan IC
    Curr Top Microbiol Immunol; 1995; 194():73-80. PubMed ID: 7895523
    [No Abstract]   [Full Text] [Related]  

  • 8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syngeneic anti-tumor globulin: suppression of mouse plasmacytoma by the IgG2 fraction.
    Harris TN; Harris S
    Adv Exp Med Biol; 1979; 121B():531-40. PubMed ID: 317563
    [No Abstract]   [Full Text] [Related]  

  • 10. Temporary disappearance ("eclipse") of LPC-1 plasmacytoma M component synthesis following tumor cell transfer.
    Frondoza CG; Trivedi SM; Humphrey RL
    Cancer Res; 1979 Jul; 39(7 Pt 1):2497-500. PubMed ID: 445451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers.
    Mokyr MB; Barker E
    Cancer Immunol Immunother; 1986; 23(1):11-9. PubMed ID: 3490305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Myc dependent initiation of genomic instability during neoplastic transformation.
    Taylor C; Jalava A; Mai S
    Curr Top Microbiol Immunol; 1997; 224():201-7. PubMed ID: 9308243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and partial characterization of the internal structural proteins from murine intracisternal A particles.
    Marciani DJ; Kuff EL
    Biochemistry; 1973 Dec; 12(25):5075-83. PubMed ID: 4209842
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy and rate of kill of tumor cells in a mouse plasmacytoma.
    Hiramoto RN; Ghanta VK
    Cancer Res; 1974 Jul; 34(7):1738-42. PubMed ID: 4833918
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.
    Hengst JC; Mokyr MB; Dray S
    Cancer Res; 1980 Jul; 40(7):2135-41. PubMed ID: 6446379
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and characterization of a cyclophosphamide-resistant mouse plasmacytoma cell line.
    Frondoza CG; Trivedi SM; Humphrey RL
    Cancer Treat Rep; 1982 Jul; 66(7):1535-44. PubMed ID: 7093969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.
    Bliskovsky V; Ramsay ES; Scott J; DuBois W; Shi W; Zhang S; Qian X; Lowy DR; Mock BA
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14982-7. PubMed ID: 14634209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MOPC-315 murine plasmacytoma as a model anticancer screen for human multiple myeloma.
    Valeriote F; Grates H
    J Natl Cancer Inst; 1986 Jan; 76(1):61-5. PubMed ID: 3455743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell neoplasm induced by subcutaneous transplantation of a plasmacytoma: characterization of tumor cells.
    Lahat N; Reisner Y; Sharon N; Moroz C
    Cell Immunol; 1977 Nov; 34(1):180-6. PubMed ID: 303154
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.